ABSTRACT STRUCTURE & RULES
Submitted abstract should be formed in these following streams:
1. Clinical audit, prospective survey or retrospective study, clinical trial, meta- analysis. The abstract should clearly state :
- Background: indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
- Methods: describe the study period / setting / location, study design, study population, data collection and methods of analysis used.
- Objective: to determine clinical characteristic of the study
- Results: present as clearly and as much in detail as possible the findings / outcome of the study, Please summarize any specific results.
- Conclusions: explain the significance of your findings / outcomes of the study for prevention, treatment, care and/or support, and future implications of the results.
2. Case Report or Case Series. The abstract should clearly state :
- Background: summarize the case in a sentence, briefly describe the importance and novelty of your case
- Case Presentation Summary: narrate your case in systematic way, include relevant positive and negative findings from history-examination-investigation, any interventions and outcome, and can include clinical photographs.
- Learning Points/Discussion: summarize the clinical impact or potential implications of the case report
Respiratory Condition and Mechanical Ventilation
No more than six keywords are required, separated by a semicolon.
- Prior to abstract submission, applicant needs to create an account and complete the registration process. After which an account will be issued with username/ID and password that will be sent to applicant’s email address to enable him/her to login to the website and submit the abstract accordingly or edit the information in necessary.
- After you submit your abstract, you can re-enter the submission link at any time to view and edit your abstract until the deadline date. Submitted abstracts cannot be modified or corrected after the submission deadline. There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.
- Please do not submit multiple copies of the same abstract.
- You will receive confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding the abstract.
- For applicants whose abstracts are rejected and decide to withdraw from attending the congress, please write an e-mail to the Secretariat of 2nd APMVF (firstname.lastname@example.org). The submission of an abstract implies your consent to publish it in the Abstract Book.
Manuscripts should be written in the English language (using American spelling). They should be typed using Goudy Old Style fonts, 1.5 spaced using 2.5 cm wide margins all around. The text is arranged as follows:
- Title page
- Text tables
- Figure legends
Please refer to the ICMJE recommendations on manuscript preparation and submission. The format may be altered for review articles, if necessary.
The title page bears:
- Name(s) of Author(s)
- Institution(s) where work was done
- “Reprint request to” information consisted of name of author to whom the reprint version should be sent with complete address, telephone number, and e-mail address.
Units and Abbreviations
Measurement unit should be stated using standard SI units.
Substantive contributions of individuals should be noted in an Acknowledgements section and entered before the Conflict of Interest (COI) statement.
Details of all funding sources for the work in question should be given in a separate section entitled ‘Funding’. This should appear before the ‘Acknowledgements’ section.
The following rules should be followed:
- The sentence should begin: ‘This work was supported by …’
- The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply ‘National Institutes of Health’ not ‘NCI’ (one of the 27 sub-institutions) or ‘NCI at NIH’ (full RIN-approved list of UK funding agencies)
- Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’
- Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
- Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
- Where individuals must be specified for certain sources of funding, the following text should be added after the relevant agency or grant number ‘to [author initials]’
An example is given here: ‘This work was supported by the Indonesia Academy of Science [grant numbers]
Figures should be limited to the number necessary for clarity and must not duplicate data given in tables or in the text. Standard submissions should have no more than 8 total figures and tables. Any number exceeding this should be designated as supplementary online-only material. They must be suitable for high-quality reproduction and should be submitted in the desired final printed size so that reduction can be avoided. Figures should be no larger than 125 (height) x 180 (width) mm (5 x 7 inches) and should be submitted under the respective header (“Figure”) and in files separates from that of the main manuscript.
Figures should be saved in TIFF format at a resolution of at least 300 pixels per inch at the final printed size for color figures and photographs, and 1200 pixels per inch for black and white line drawings. While some formats can be converted into TIFFs by the publisher, conversion may alter the tones, resolution and contrast of the image. Digital colour art should be submitted in CMYK rather than RGB format, since the printing process requires colors to be separated into CMYK, and this conversion can alter the color intensity and brightness. Please keep in mind that colors can appear differently on different screens and printers.
Faint shading or stippling will be lost upon reproduction and should be avoided and heavy shading or stippling may appear black. Lines and symbols should be drawn boldly enough to stand reduction to the desired size. For graphs where reduction to one-half in linear dimensions is intended, a suitable thickness for the axis would be 0.3 mm and for the other lines 0.4 or 1.0 mm depending on the complexity of the graph. The preferred symbols are closed circle, open circle, closed square, open square, closed triangle, and open triangle and should be no smaller than 2 mm (height/diameter).
Photographs should be of sufficiently high quality, i.e. JPG or TIFF formats with a minimum file size of 1 MB, and 300 dpi. Please ensure that the photographs are of high quality with respect to detail, contrast, and low noise, to enable them to withstand loss of contrast and detail inherent in the printing process.
There are no charges for color figures. Color plates should be combined to make a single composite figure whenever possible.
A separate typewritten, double-spaced list of legends of all figures must be supplied and included in the text file. Each legend should contain sufficient explanation to be meaningful without cross-referencing. A scale of the original should be included in the legend unless already indicated in the picture. A description of the symbols used in the figures should be written out in full. Please do not include the character symbol in the legend. All labels used in figures should be in lower case in both the figure and the legend.
Tables should be typed with single spacing, but minimizing redundant space, and each table should be placed in separate pages. Wherever possible, tables should be submitted in portrait – as opposed to landscape – layout. Each table should be numbered in sequence using Arabic numerals. Tables should also have a title above and an explanatory footnote below.
The references used in this journal follow the “Uniform requirements for manuscripts submitted to biomedical journals” (updated February 2006) published by International Committee of Medical Journal Editors with some modifications. References cited should be numbered consecutively in superscript by Arabic numerals in the order they first appear in the text. Identify also references in the tables and legends by Arabic numerals in superscript. Please make sure that every numbered reference in the text appears in the reference list, and vice versa. Reference cited only in tables or in legends should be numbered in accordance established by their first identification in the text. List authors, years, volume, and inclusive pages (the beginning and the last pages) of all journal references, and specific page numbers for all book references as shown below. Avoid referencing abstract, but if they are used, indicate them as such by the abbreviation [abstr] after the title. Do not use periods or semicolons after authors initials or after abbreviations. Personal communications, unpublished observations, and manuscripts submitted but not yet accepted for publication do not constitute references. Limit the use of electronic sources that have not been published in journals. Please rigidly follow the following examples of the most frequently used references. Personal communications, manuscripts in preparation and other unpublished data are not cited in the reference list but are mentioned in the text in parentheses. Titles of journals should be abbreviated in accordance with Medline. Complete information should be given for each reference, including title of article, abbreviated journal title and inclusive pagination. All authors should be listed. Authors are encouraged to use referencing software for the manuscript.
List all authors when six or less, when seven or more, list only first six, and add et al.
Michelle L, Mayer ML, Preisse JS. The changing composition of the pediatric medical subspecialty workforce. Pediatrics 2005;116:833-40.
Sosrosumihardjo R, Firmansyah A, Rasad A, Hardjodisastro D, Ridwan E, Wanandi SI, et al. Morphology and disaccharidase activity of small intestinal mucosa in post-weaning induced malnourished rats and after realimentation. Paediatr Indones 2006;46:229-35.
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 2002;42 Suppl 2:S93-9.
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human breast milk. Pediatrics 1983;72:375-83.
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.
Arnold L, Stern DT. What is medical professionalism? In: Stern DT, editor. Measuring medical professionalism. Oxford: Oxford University Press; 2006. p. 15-37.
Dooley JM, Gordon KE. Headache in childhood. In: Feldman W, editor. Evidence-based pediatrics. Hamilton: BC Decker; 2000. p. 243-65.
Armitage P, Berry G, Matthews GNS. Statistical methods in medical research. Massachussets: Blackwell Publ; 2002. • Murray R. How to write a thesis. Philadelphia: Open University Press; 2002.
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
Sebodo T. Response of plasma and yeast-derived hepatitis vaccines in children. Paediatr Indones. In press 2002.
Sjarif DR. Glycerol kinase deficiency [dissertation]. Utrecht: University Medical Center Utrecht; 2000.
Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from:http://www.nursingworld.org/AJN/2002/june/ Wawatch.htm
Evidence based medicine tool kit.
Available from: url: http://www.med.ualberta.ca/ebm/ebmintro.htm.
American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens].
Available from: http://www.ama-assn.org/ ama/pub/category/1736.html.